Quant Healthcare Fund Direct Growth

Equity
Direct
Sector - Healthcare
Quant Healthcare Fund Direct Growth

About the Fund

Quant Healthcare Fund Direct Growth is an equity fund. This fund was started on 18 July, 2023. The fund is managed by Sanjeev Sharma, Ankit A. Pande. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Quant Healthcare Fund Direct Growth has ₹302 Cr worth of assets under management (AUM) as on Jun 2024 and is less than category average.
  2. The fund has an expense ratio 0.7.

Returns

Quant Healthcare Fund Direct Growth has given a CAGR return of 59.79% since inception. Over the last 1 year the fund has given a CAGR return of 60.96%.

Holdings

Quant Healthcare Fund Direct Growth has allocated its funds majorly in Health, Cash Equivalent. Its top holdings are Poly Medicure Ltd, GlaxoSmithKline Pharmaceuticals Ltd, Aurobindo Pharma Ltd, Pfizer Ltd, Zydus Lifesciences Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 15%
For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefit
Dividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.

Investment objective of Quant Healthcare Fund Direct Growth

The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 1000.00. Quant Healthcare Fund Direct Growth has no lock in period.

Fund Performance
zero opening, trading, fund transfer fee
1292 people have invested ₹ 1.3Cr in Quant Healthcare Fund Direct Growth in the last three months

Fund Overview

Expense ratio0.68%
Benchmark
S&P BSE Healthcare PR
AUM₹302 Cr
Inception Date18 July, 2023
Min Lumpsum/SIP₹5000/₹1000
Exit Load
1%
Lock InNo Lock-in
TurnOver
0%
Risk
Risk meter
pointer
Very High Risk

Fund Distribution
as on (30-Jun-24)

  • Equity 97.4%

  • Debt & Cash 2.7%

Small cap
64.1%

Mid cap
24.5%

Large cap
6.9%

Sector Allocation

Jun'24

May'24

Apr'24

Health
100%
All changes are between Apr'24 and Jun'24

Returns for the month of Jun

  • Gainers

  • Losers

Top Growth Drivers
1M Return
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Ltd
13.4%

Sanjeev Sharma
Sanjeev Sharma
Fund Manager of Quant Healthcare Fund Direct Growth, since 18 July 2023
Ankit A. Pande
Ankit A. Pande
Fund Manager of Quant Healthcare Fund Direct Growth, since 18 July 2023

Quant Healthcare Fund Direct Growth Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 59.79% since inception which is more than its category average return of 23.79%
Fund Allocations

Fund Allocations

This fund has an allocation of 97.35% in Equity, 0% in Debt and 2.65% in Cash related instruments
AUM size ₹302 Cr

AUM size ₹302 Cr

This fund has AUM of ₹302 Cr which is less than its category average of ₹ 1743 Cr
Expense Ratio 0.68%

Expense Ratio 0.68%

This fund has an expense ratio of 0.68% which is less than its category average expense ratio of 1.44%

Frequently Asked Questions

The current NAV of Quant Healthcare Fund Direct Growth is ₹16.3 as on 25-Jul-2024.
Existing (Absolute + CAGR) as on 25-Jul-2024.
Quant Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
6.97%
6.97%
6 Month Returns
23.51%
23.51%
1 Year Returns
60.96%
60.96%
3 Years Returns
0%
0%
5 Years Returns
0%
0%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
0.68% as on June 2024
₹302 Cr as on June 2024
Poly Medicure Ltd(9.5%), GlaxoSmithKline Pharmaceuticals Ltd(8.85%), Aurobindo Pharma Ltd(8.68%), Pfizer Ltd(8.14%), Zydus Lifesciences Ltd(6.92%) as on June 2024
The alpha ratio for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Quant Healthcare Fund Direct Growth
-
-
-
As on June 2024
The alpha for Quant Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Quant Healthcare Fund Direct Growth
-
-
-
As on June 2024
The Beta for Quant Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Quant Healthcare Fund Direct Growth
-
-
-
As on June 2024
The sharpe ratio for Quant Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Quant Healthcare Fund Direct Growth
-
-
-
As on June 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sanjeev Sharma, Ankit A. Pande are the fund managers of Quant Healthcare Fund Direct Growth
The Exit load of Quant Healthcare Fund Direct Growth is 1%